K190416 is an FDA 510(k) clearance for the Dome Electrode. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.
Submitted by Coapt, LLC (Chicago, US). The FDA issued a Cleared decision on April 4, 2019 after a review of 42 days - a notably fast clearance cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.
Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.